Operational Considerations for Maintaining Essential Services and Providing Prevention, Care, and Treatment for Tuberculosis (TB) in Low-Resource Non-US Settings During the COVID-19 Pandemic [open pdf - 150KB]
From the Introduction: "Despite being preventable and curable, tuberculosis (TB) remains the world's deadliest infectious disease, taking the lives of 1.5 million persons each year. One-fourth of the world's population--nearly 2 billion people--are infected with TB. In 2018, 10 million people, including 1.1 million children, became ill with TB disease. The global community has made substantial progress in the fight to end TB, and it is critical that the progress made in TB prevention, care, and treatment is not reversed by the COVID-19 [coronavirus disease 2019] pandemic. Modeling highlights the potentially devastating effects of the COVID-19 pandemic on global TB programs, which could result in an additional 6.3 million TB cases and 1.4 million TB deaths by 2025. Furthermore, a 25% global reduction in TB detection over 3 months could lead to a 13% increase in TB deaths, setting TB mortality levels back to what they were 5 years ago."
U.S. Centers for Disease Control and Prevention: https://www.cdc.gov/